Publications
- When not even four ALK inhibitors are enough2020 | Faculty of Medicine in Pilsen
- Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary PrognostiPrognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part2019 | Faculty of Medicine in Pilsen
- Modern treatment of non-small cell lung carcinoma2017 | Faculty of Medicine in Pilsen
- Crizotinib - Still "gold standard" for patients with pulmonary adenocarcinoma with ALK translocation?2017 | Faculty of Medicine in Pilsen
- Successful Therapy of Czech Patients with ROS1 Translocation by Crizotinib2016 | Faculty of Medicine in Pilsen
- The coincidence of tumorlets and metastases of lung in a patient with a history of malignant melanoma2016 | Faculty of Medicine in Pilsen
- LUX-LUNG 7 - new look at the first line treatment for patients with frequent EGFR mutations?2016 | Faculty of Medicine in Pilsen
- Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically treated patients with non-small cell lung cancer2014 | Faculty of Medicine in Pilsen
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
- Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC2023 | Faculty of Medicine in Pilsen, Faculty of Science, Central Library of Charles University
Loading network view...